戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1  not significantly associated with incident ASCVD (n = 1386 events; median follow-up, 25.2 years; hazard ratio [HR], 1.06
2  hazard ratio [HR], 1.06 [95% CI, 0.89-1.26]), HF (n = 1396 events; HR, 0.91 [95% CI, 0.76-1.09]), or CKD (n = 2433 event
3 396 events; HR, 0.91 [95% CI, 0.76-1.09]), or CKD (n = 2433 events; HR, 0.98 [95% CI, 0.65-1.11]).
4 ased incidence of recurrent stroke or TIA: 2.32 versus 0.75 events per 100 patient-years (hazard ratio [HR], 3.05 [95% CI
5                                                     Adverse events were reported in 58.4% of patients; most (94.4%) were
6 5), any adverse event (OR 1.55, 95% CI: 1.03-2.33), adverse events due to decreased appetite (OR 3.56, 95% CI: 1.94-6.53)
7 nents, biological and pharmacokinetic measures, and adverse events graded 2 or higher.
8 redictors for discontinuation due to inefficacy and adverse events.
9       By a stepwise method to capture all available adverse events, we first extracted data on myelodysplastic syndrome a
10 tient's ICU discharge date to identify and classify adverse events.
11 ed according to the Common Terminology Criteria for Adverse Events (CTCAE), version 5, and its relationship with parenchy
12 nts, defined by the Common Terminology Criteria for Adverse Events, do not provide information on the time profile of the
13 ity tables that include the incidence of high-grade adverse events, defined by the Common Terminology Criteria for Advers
14                          There was no difference in adverse events between randomised groups.
15 VR) is associated with a risk of procedural serious adverse events (SAE) and exposure to ionizing radiation.
16 adverse event (OR 2.30, 95% CI: 1.18-4.48), serious adverse events related to abnormal liver function tests (OR 11.19, 95
17                                       Eight serious adverse events were reported with capsular release and two with manip
18 ot provide information on the time profile of these adverse events or reflect the continuous, lower grade symptomatic tox
19 r any reason (OR 2.61, 95% CI: 1.38-4.96) or due to adverse events (OR 2.65, 95% CI: 1.04-6.80), any serious adverse even
20                            There were no unexpected adverse events with (177)Lu-PSMA retreatment.
21     To validate these self-reports, medical records for all events at every hospital where the patient reported receiving
22 lytical approaches in assessing total ischemic and bleeding events after percutaneous coronary intervention in the GLOBAL
23 Genetic risk scores were not associated with cardiovascular events in 357 882 unrelated individuals from UK Biobank.
24 cidence of major adverse cardiovascular and cerebrovascular events was higher in the FFR-guided PCI versus the CABG group
25  how adult reproductive function can be shaped by childhood events.
26 ly reduce the primary cardiovascular end point of major CVD events (composite of myocardial infarction, stroke, and CVD m
27 rovide enhanced spatial and temporal coverage of ecological events.
28 ses of 47 teeth from 15 individuals with known life history events and were able to detect reproductive events and menopa
29                                                         ILD events were more common among those with early/mild ILA at en
30 we tested the hypothesis that the physiologically impactful events of parturition and menopause are recorded in dental ce
31 ic regression analyses) aimed to detect any combinations of events predicting poor outcome as defined by a cumulative CCI
32            Chronic pain may sap the motivation for positive events and stimuli.
33  distinct biological and disease initiation and progression events associated with Chr1- and Chr10-directed AMD.
34  overview of how ratcheted processivity emerges from pulsed events, and how tissue-level mechanics are the coordinated ou
35                      We previously described the regulatory events that control the timely synthesis of Ndc80.
36  for transport (ESCRTs) mediate diverse membrane remodeling events.
37  acquired for adjudication, not just those for the reported events.
38 wn life history events and were able to detect reproductive events and menopause in all females.
39 and (full visible range) lossless multiple light scattering events, enabled by a highly porous (>99.99%) non-absorbing na
40 bers available for binding, rather than specific signalling events.
41 s of large (>100 kilobases (kb)) inversions but not smaller events.
42  whether those with highly variable SI respond to stressful events with increases in SI.
43 crimination and reclassification for CHD but not for stroke events.
44 ng pathway downstream of PAR4 activation that leads to such events.
45 orce-activatable emitter reporting single-molecular tension events and the associated cellular force nanoscopy (CFN).
46  scale of seconds, examining the relationship between these events and those observed by smFRET.
47 rovide a framework for predicting both when and where these events may occur.
48 ascades, in concert with NF-kappaB-mediated transcriptional events, control the metabolism at several levels.
49  (also known as KDM6A) and activation of the RTK FGFR3, two events that commonly cooccur in muscle invasive bladder tumor
50                                           Extreme heat wave events are now causing ecosystem degradation across marine ec